| 注册
首页|期刊导航|中国药理学通报|神经药理学发展与前沿

神经药理学发展与前沿

郜丹 朱意攀 李林 张兰

中国药理学通报2026,Vol.42Issue(9):1607-1612,6.
✕
中国药理学通报2026,Vol.42Issue(9):1607-1612,6.DOI:10.12360/CPB202604035

神经药理学发展与前沿

Developments and frontiers in neuropharmacology

郜丹 1朱意攀 1李林 1张兰1

作者信息

  • 1. 首都医科大学宣武医院药学部,北京 100053
  • 折叠

摘要

Abstract

Neuropharmacology focuses on the interactions be-tween exogenous active substances and the nervous system,pro-viding essential foundations for the diagnosis and treatment of neuropsychiatric disorders.This review traces the development of this field,elucidating research advances from neurotrans mitter-based mechanisms to precision targets and translational medicine.It further explores therapeutic breakthroughs in neu-rodegenerative and psychiatric disorders.Addressing challen ges such as mechanistic complexity,the blood-brain barrier and individual variability,the review proposes innovative directions for multidisciplinary integration,precision regulation and per-sonalized treatment.

关键词

神经药理学/神经精神疾病/药物研发/国内研究进展/个体化治疗/疾病修饰治疗

Key words

neuropharmacology/neuropsychiatric disorders/drug discovery and development/domestic research progress/personalized treatment/disease-modifying therapy

分类

医药卫生

引用本文复制引用

郜丹,朱意攀,李林,张兰..神经药理学发展与前沿[J].中国药理学通报,2026,42(9):1607-1612,6.

基金项目

国家自然科学基金资助项目(No 82574602) (No 82574602)

中国药理学通报

1001-1978

访问量0
|
下载量0
段落导航相关论文